Menu

Post image 1
Post image 2
Post image 3
1 / 3
0

Capricor Therapeutics, Inc. (CAPR) Q1 2026 Earnings Call Transcript

Seeking Alpha·SA Transcripts·20 days ago
#L1kYqsAr
Reading 0:00
15s threshold

Capricor Therapeutics, Inc. ( CAPR ) Q1 2026 Earnings Call May 12, 2026 4:30 PM EDT Company Participants Anthony Bergmann - CFO & Corporate Treasurer Linda Marbán - Co-Founder, President, CEO & Director Conference Call Participants Leland Gershell - Oppenheimer & Co. Inc., Research Division Edward Tenthoff - Piper Sandler & Co., Research Division Kristen Kluska - Cantor Fitzgerald & Co., Research Division Madison Wynne El-Saadi - B. Riley Securities, Inc., Research Division Michael Okunewitch - Maxim Group LLC, Research Division Catherine Novack - JonesTrading Institutional Services, LLC, Research Division Matthew Venezia - Alliance Global Partners, Research Division Boobalan Pachaiyappan - ROTH Capital Partners, LLC, Research Division Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics First Quarter 2026 Conference Call. [Operator Instructions] This call is being recorded on Tuesday, May 12, 2026.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.

Read More